Chr. Hansen Natural Colors inaugurates state-of-the-art R&D center
Ramping up pigment, formulation and application capabilities to keep pioneering the natural colors industry
Ramping up pigment, formulation and application capabilities to keep pioneering the natural colors industry
Delivers on guidance, launched new strategy and carried through three acquisitions in spite of COVID-19
New partnership sets out to democratize fermentation and create new solutions for a climate friendly food system
Chr. Hansen to sell its Natural Colors business, the leading global developer and manufacturer of natural coloring ingredients for food and beverages, to EQT IX Natural Colors’ underlying market is supported by favorable secular megatrends, such as increasing consumer awareness around health and the environment, the ongoing transition from synthetic coloring components to natural ingredients, and
Chr. Hansen Holding A/S (“Chr. Hansen”) has today entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH (“Jennewein”), which is a leading player in the Human Milk Oligosaccharides (“HMO”) market
The acquisition is fully in line with Chr. Hansen’s 2025 Strategy of pursuing bolt-on acquisitions that extend and strengthen its microbial and fermentation technology
Chr. Hansen launches a new FruitMax® blue
Chr. Hansen launches a clean label FruitMax® product from turmeric
F-DVS® Pure Appeal: New Chr. Hansen culture for pizza reduces degree of browning by up to 100 percent
2025 Strategy founded in strong purpose: “Grow a better world. Naturally”
Exciting growth and innovation opportunities across food, health and agriculture; new lighthouse in Fermented Plant Bases announced
Chr. Hansen to focus investments on Microbial Platform going forward; strategic review of Natural Colors progressing well
New long-term financial and non-financial ambitions until 2024/25
C
As promised, Chr. Hansen celebrates successful reception of CHY-MAX® Supreme by donating money to Danish NGO for each industrial trial with the innovative product
Chr. Hansen Holding A/S (“Chr. Hansen”) today announced that it has successfully completed the acquisition of UAS Laboratories LLC (“UAS Labs”) following the satisfaction of all closing conditions.
With UAS Labs, Chr. Hansen further strengthens its microbial platform and Human Health business by moving into the highly attractive space of multi-species, high-potency blends and broadening its
Chr. Hansen Holding A/S has today appointed Lise Skaarup Mortensen as new Chief Financial Officer (CFO). Lise is an experienced international leader with a strong track-record and a passion for leadership who joins from a position as CFO at Microsoft Germany
Lise Skaarup Mortensen (52) has a strong financial background with many years of experience in large international companies and has for t
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.
Boege Allé 10-12
DK-2970 Hoersholm
Denmark